Corporate Profile

Acutus Medical is an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated. We are committed to advancing the field of electrophysiology with a unique array of products and technologies which will enable more physicians to treat more patients more efficiently and effectively. Through internal product development, acquisitions and global partnerships, we have established a global sales presence delivering a comprehensive portfolio of highly differentiated electrophysiology products that provide our customers with a complete solution for catheter-based treatment of cardiac arrhythmias. Founded in 2011, Acutus is based in Carlsbad, California.

Stock Information

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Investor Relations

Press Releases

29 Jul '21
Acutus Medical to Announce Second Quarter 2021 Financial Results
CARLSBAD, Calif., July 29, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced today it will release its financial results for the second quarter of 2021 on
14 Jul '21
Acutus Medical, Inc. Announces Pricing of Public Offering of Common Stock
CARLSBAD, Calif., July 14, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (Nasdaq: AFIB) (“Acutus”) today announced the pricing of its underwritten public offering of 5,500,000 shares of its common stock at a price to the public of $14.00 per share. All of the shares of common stock are being

View All Releases

Recent Events

View All Events

SEC Filings

Filing date Description Form

A statement of beneficial ownership of common stock by certain persons

 SC 13G

An amendment to a SC 13D filing

 SC 13D/A

Statement of changes in beneficial ownership of securities

 4
View All SEC Filings